U.S. Machinery Stock News

NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Shrinking TTM Loss At 10x Genomics (TXG) Tests Bearish Earnings Narratives

10x Genomics FY 2025 earnings snapshot 10x Genomics (TXG) closed FY 2025 with Q4 revenue of US$166.0 million and a basic EPS loss of US$0.13, alongside trailing twelve month revenue of US$642.8 million and a TTM EPS loss of US$0.35 that keeps the focus squarely on the income statement. Over recent quarters the company has seen revenue range between US$149.0 million and US$172.9 million per quarter, with basic EPS swinging from a profit of US$0.28 in Q2 2025 to losses of US$0.28 in Q1, US$0.22...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Caesars Entertainment Expands Flamingo And Tahoe Resorts With Undervalued Shares

Caesars Entertainment (NasdaqGS:CZR) has announced a substantial renovation and expansion of the Flamingo Las Vegas, one of its flagship properties on the Strip. The company is also moving into the second phase of the transformation at Caesars Republic Lake Tahoe, further reshaping its resort footprint in that market. Both projects focus on upgrading guest experience and facilities at core assets in Caesars Entertainment’s hospitality and gaming portfolio. For investors, these projects...
NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Assessing Innospec (IOSP) Valuation After Analyst Upgrade And Insider Share Purchase

Innospec (IOSP) has come into focus after a research firm shifted its recommendation to buy and a company director added to their holdings, developments that may be shaping recent trading and investor interest. See our latest analysis for Innospec. Recent trading reflects a mixed picture, with the share price at US$86.58 after a 30 day share price return of 7.09% and a 90 day share price return of 16.86%. However, the 1 year total shareholder return is an 18.23% loss, suggesting that shorter...
NYSE:FLO
NYSE:FLOFood

Flowers Foods (FLO) Quarterly Loss And 1.6% Margin Test Bullish Earnings Narratives

Flowers Foods (FLO) just posted fourth quarter FY 2025 revenue of US$1.2b with a basic EPS loss of US$0.32, while trailing twelve month EPS came in at US$0.40 on revenue of US$5.3b. The company has seen quarterly revenue move from US$1.1b and EPS of US$0.20 in Q4 2024 to US$1.2b and EPS of US$0.19 in Q3 2025 before the latest quarterly loss, setting up a results season where investors are weighing weak reported profitability against forecasts for stronger earnings ahead. With net profit...
NYSE:ARMK
NYSE:ARMKHospitality

How Investors Are Reacting To Aramark (ARMK) Reaffirmed 2026 Guidance And Buybacks Amid Mixed Q1 Results

In the past week, Aramark reported first‑quarter fiscal 2026 results showing sales of US$4,831.55 million, higher than a year earlier, while net income and earnings per share from continuing operations were slightly lower; the company also completed a US$168.56 million buyback program and affirmed a quarterly dividend of US$0.12 per share. Management reiterated full‑year 2026 guidance, including expected revenue between US$19.55 billion and US$19.95 billion and mid‑single‑digit organic...
NYSE:IT
NYSE:ITIT

Gartner (IT) Margin Reset To 11.2% Challenges Bullish Earnings Narratives

Gartner FY 2025 earnings snapshot Gartner (IT) has wrapped up FY 2025 with Q4 revenue of US$1.8b and basic EPS of US$3.36, alongside net income of US$242.2m, setting the tone for how investors will read the year as a whole. Over recent quarters, the company has seen revenue move from US$1.5b in Q1 2025 to US$1.7b in Q2 and US$1.5b in Q3. Basic EPS has ranged from US$2.73 to US$3.36 across the year, giving you a clear view of how earnings are tracking through the cycle. With trailing net...
NYSE:PINE
NYSE:PINEREITs

How Investors Are Reacting To Alpine Income (PINE) Balancing Higher Dividends With Losses And Cheaper Credit

In early February 2026, Alpine Income Property Trust reported full-year 2025 results showing higher sales and revenue but a net loss, while simultaneously amending and expanding its unsecured credit facility and announcing both a higher common dividend and a declared preferred dividend payable on March 31, 2026. Together, the return to a loss-making position alongside a 5.3% common dividend increase and cheaper, longer-dated credit lines raises important questions about how Alpine is...
NYSE:KNSL
NYSE:KNSLInsurance

Kinsale Capital Group Q4 Combined Ratio Of 71.7% Reinforces Quality Underwriting Narrative

Kinsale Capital Group (KNSL) has wrapped up FY 2025 with fourth quarter revenue of US$483.3 million and EPS of US$6.01, underpinned by net income of US$138.6 million and a combined ratio of 71.7%. The company has seen quarterly revenue move from US$412.1 million in Q4 2024 to US$423.4 million in Q1 2025, US$469.8 million in Q2, US$497.5 million in Q3 and US$483.3 million in Q4 2025. EPS shifted from US$4.71 in Q4 2024 through US$3.85, US$5.79 and US$6.12 across the first three quarters of...
NYSE:VLO
NYSE:VLOOil and Gas

Is Valero Energy (VLO) Still Attractive After A 52% One Year Share Price Surge?

If you are wondering whether Valero Energy is still good value after its recent run, you are not alone. This article looks squarely at what you are paying for each dollar of the business. The share price closed at US$200.17, with returns of 7.3% over 30 days, 21.1% year to date, 52.3% over 1 year and 69.2% over 3 years, while the last 7 days showed a 1.2% decline. Recent headlines around Valero Energy have centered on its role as a large US refiner and how investors are weighing fuel demand...
NasdaqGS:FHB
NasdaqGS:FHBBanks

Assessing First Hawaiian (FHB) Valuation After Recent Share Price Swings

First Hawaiian (FHB) has drawn investor attention after recent share price swings, including a small 1 day gain alongside a decline over the past week, prompting closer focus on its fundamental profile. See our latest analysis for First Hawaiian. That small 0.8% 1 day share price gain sits against a softer 7 day share price return of a 3.4% decline, while a 90 day share price return of 8.5% and 1 year total shareholder return of 1.2% point to modest, but still positive, longer term...
NYSE:RPT
NYSE:RPTMortgage REITs

Rithm Property Trust (RPT) Q3 Revenue Of US$3.6 Million Tests Bullish Growth Narratives

Rithm Property Trust (RPT) has put out its latest FY 2025 numbers with third quarter total revenue of US$3.6 million and basic EPS of a US$0.21 loss, following second quarter revenue of US$4.7 million with EPS of US$0.08. Over recent quarters, the company has seen revenue move from US$5.4 million in Q4 2024 to a US$0.9 million loss in Q1 2025, alongside EPS shifting from US$0.35 to a US$0.49 loss. This leaves investors weighing how much of the current earnings profile reflects temporary...
NYSE:QSR
NYSE:QSRHospitality

Restaurant Brands International (QSR) Margin Compression Challenges Bullish Profitability Narrative

Restaurant Brands International (NYSE:QSR) closed out FY 2025 with Q4 revenue of US$2.5b and basic EPS of US$0.69, while trailing twelve month revenue came in at US$9.4b with EPS of US$2.74. Over recent periods, revenue has moved from US$2.3b in Q4 2024 to US$2.5b in Q4 2025, and trailing EPS has shifted from US$3.20 to US$2.74, giving investors a clear read on both the top line and per share earnings trend as the year wrapped up. With a trailing net profit margin of 9.6% versus 12.1% the...
NYSE:NUS
NYSE:NUSPersonal Products

Nu Skin Enterprises (NUS) Return To Profitability Challenges Longstanding Bearish Narratives

Nu Skin Enterprises (NUS) has just reported its FY 2025 numbers with fourth quarter revenue of US$370.3 million and basic EPS of US$0.30, alongside full year trailing twelve month revenue of about US$1.6 billion and basic EPS of US$2.21. Over recent quarters, revenue has moved from US$445.6 million and basic EPS of a loss of US$0.73 in Q4 2024 to US$364.5 million with EPS of US$2.16 in Q1 2025, then US$386.1 million and US$0.43 in Q2, US$364.2 million and US$0.35 in Q3, and now US$370.3...
NYSE:BIRK
NYSE:BIRKLuxury

Birkenstock Q1 Beat, Retail Expansion And Buyback Contrast With Weak Share Price

Birkenstock Holding (NYSE:BIRK) reported robust first quarter revenue growth that exceeded its full year guidance. The company highlighted broad based strength across regions, with especially rapid expansion in APAC. Birkenstock continued to grow its global retail footprint and advanced its push toward four season footwear offerings. Management approved a new €200 million share repurchase program, signaling confidence in the brand and balance sheet. Birkenstock comes into this update with...
NasdaqCM:APPS
NasdaqCM:APPSSoftware

A Look At Digital Turbine (APPS) Valuation After Raised 2026 Guidance And Return To Quarterly Net Income

Digital Turbine (APPS) is back on investors’ radar after raising its 2026 revenue outlook to US$553 million to US$558 million and reporting third quarter results that showed a shift from a net loss to net income. See our latest analysis for Digital Turbine. The recent guidance hike and return to quarterly net income have arrived during a weak patch for the stock, with a 30 day share price return of a 20.04% decline and a 1 year total shareholder return of a 32.31% loss indicating that...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

A Look At Alliance Resource Partners (ARLP) Valuation After Trump’s Coal Support Executive Order

Alliance Resource Partners (ARLP) moved into focus after President Donald Trump signed an executive order directing the Department of War to prioritize electricity purchases from coal fired plants and to commit US$175 million to upgrade six coal facilities. See our latest analysis for Alliance Resource Partners. The policy boost comes on top of steady market gains, with a 7 day share price return of 5.95% and a year to date share price return of 10.86%, while the 5 year total shareholder...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) TTM US$575 Million Loss Tests Bullish Profitability Narratives

Ultragenyx Pharmaceutical (RARE) just closed out FY 2025 with fourth quarter revenue of US$207 million and a basic EPS loss of US$1.29, while trailing twelve month revenue came in at US$673 million against a TTM basic EPS loss of US$5.83. The company has seen quarterly revenue move from US$164.9 million in Q4 2024 to US$207 million in Q4 2025, alongside quarterly basic EPS losses ranging between US$1.17 and US$1.81 over the year. For investors, the latest numbers keep the focus squarely on...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is It Too Late To Consider American Superconductor (AMSC) After Its Recent Price Surge?

If you are wondering whether American Superconductor’s share price still makes sense at current levels, this article walks through what the numbers say about value rather than hype. The stock recently closed at US$34.26, with returns of 21.6% over 7 days, 9.6% over 30 days, 8.5% year to date, 9.9% over 1 year and a very large gain over 3 years, with a 5 year return of 31.9%. These moves have put American Superconductor back on many investors’ watchlists, as they reassess whether the current...
NYSE:KIM
NYSE:KIMRetail REITs

Kimco Realty Dividend Hike Meets Record Occupancy And Leasing Strength

Kimco Realty (NYSE:KIM) has approved a 4% increase to its quarterly common dividend for 2025. The company reported record overall portfolio occupancy for 2025. Kimco also recorded its highest quarterly new leasing volume in more than 10 years. Kimco Realty, a major owner of open air shopping centers, sits at the intersection of retail property and consumer spending trends. For investors following real estate income names, a 4% dividend increase from NYSE:KIM and record portfolio occupancy...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape Edges Toward Commercial Scale With Eagle Line And Licensing Shift

QuantumScape launched its Eagle Line pilot production line, targeting scalable solid state battery output. The company integrated its Cobra manufacturing process into Eagle Line to support higher volume production. QuantumScape expanded agreements with major automotive OEMs and recorded its first customer billings. PowerCo shifted to a licensing only model with QuantumScape, changing the risk and capital mix of that relationship. The company moved into non automotive markets such as data...
NYSE:CBL
NYSE:CBLRetail REITs

CBL And Associates Properties (CBL) FFO Stability Supports Bullish Narratives On Earnings Quality

CBL & Associates Properties (CBL) has just posted its FY 2025 third quarter numbers, with total revenue of US$139.3 million, basic EPS of US$2.44, and net income of US$74.3 million setting the tone for the latest update. The company has seen revenue move from US$125.1 million in Q3 FY 2024 to US$139.3 million in Q3 FY 2025, while trailing twelve month basic EPS stands at US$4.06, alongside a net profit margin of 22.3% versus 6.1% a year earlier, helped by a US$131.2 million one off gain...
NasdaqCM:RCEL
NasdaqCM:RCELBiotechs

Avita Medical (RCEL) TTM US$48.6m Loss Tests Bullish Profitability Narratives

AVITA Medical (RCEL) has just wrapped up FY 2025 with Q4 revenue of US$17.6 million, a basic EPS loss of US$0.38, and net income loss excluding extra items of US$11.6 million, giving investors a clear read on how the year finished. Over recent quarters, the company has seen revenue range from US$17.1 million to US$18.5 million, while quarterly basic EPS losses have moved between US$0.38 and US$0.53 as management pushes ahead with commercial execution and product launches. For investors, the...
NYSE:AIZ
NYSE:AIZInsurance

Assurant Enters Real Estate With Home Warranty As Shares Screen Undervalued

Assurant, Inc. (NYSE:AIZ) launched Assurant Home Warranty through a partnership with Compass International Holdings. The move introduces Assurant into the real estate services space, offering home warranty products to agents and consumers. The rollout is tied to major real estate brands with a nationwide reach across the U.S. market. For investors watching NYSE:AIZ, this partnership links a long standing specialty insurance and protection company directly to the real estate transaction...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Elanco Board Changes Raise Questions On Governance And Valuation

Elanco Animal Health (NYSE:ELAN) announced that founding Chairman R. David Hoover will retire from the board and will not stand for re election. Dr. Deborah Kochevar, chair of the Innovation, Science and Technology committee, will also conclude her board service and not stand for re election. The leadership transition marks a change in board oversight following Hoover's role in guiding the company through its IPO and early years as a public company. Elanco Animal Health focuses on medicines...